申请人:HOFFMANN LA ROCHE
公开号:WO2010066629A2
公开(公告)日:2010-06-17
The application discloses compounds of the Formula (A) wherein: or a pharmaceutically acceptable salt thereof, for the treatment of pain, genitourinary conditions, gastroenterological conditions, and respiratory conditions, via inhibition of P2X3 and P2X2/3.